Upcoming Visits

Upcoming FDA Visits:

Dates Topic FDA Visitors

March 29-30, 2017

 

Pharmacovigilence

Robert Ball, MD | Deputy Director, Office of Surveillance and Epidemiology, CDER

 

April 19-20, 2017

 

Orphan Drugs

 

Ilan Irony, MD | Chief, General Medicine Branch/OTAT, CBER

 

May 11-12, 2017

 

Biostatistics

 

TBD

 

June 5-8, 2017

 

Patient Preference

 

Heather Benz, PhD | Medical Device Fellow, External Expertise and Partnerships, CDRH
Martin Ho, MSc | Associate Director of Quantitative Innovation, Office of Surveillance and Biometrics, CDRH
Anindita Saha | Director, External Expertise and Partnerships, CDRH
Vasum Peiris, MD | Pediatric Chief Medical Officer, CDRH

 

August 2017

 

CRISPR/Cas9 Genome Editing

 

Jakob Reiser, PhD | Principal Investigator, Division of Cellular & Gene Therapies/OTAT, CBER
Ying Huang, PhD| Pharmacologist, Division of Clinical Evaluation & Pharmacology/Toxicology/OTAT, CBER

 

September 2017

 

Oncology Products

Geoffrey Kim, MD | Director, Division of Oncology Products 1/OHOP, CDER

 

September 2017

Cellular Immunotherapies

Graeme Price, PhD | Research Microbiologist, Division of Cellular & Gene Therapies/OTAT, CBER
Kristin Baird, MD | Medical Officer, Division of Clinical Evaluation & Pharmacology/Toxicology/OTAT, CBER

 

TBD

 

National Center for Toxicological Research

 

TBD

 

Public lectures are posted under the "Events" link on the left menu bar.  Please contact Lawrence Lin to learn more about any of the upcoming visits.